{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T08:55:18Z","timestamp":1792400118654,"version":"4.4.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Digital technologies can improve adherence to tuberculosis (TB) treatment. We studied the impact of digitizing TB treatment monitoring on adherence among TB patients in Wuhan, China, during 2020-2021.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We compared an electronic system introduced to monitor TB medication adherence (e-Patient Service System; e-PSS) with the p paper-based standard of care (TB Control Information System; TCIS) in terms of prescribed TB treatment doses taken by patients and patient outcome after six months of follow up. We designed a cross sectional study using retrospective data for all drug susceptible pulmonary TB patients recorded on both systems. The main indicators were: compliant first follow up visit (within 3 days of start of treatment); medication adherence (80% or more of monthly doses taken); and end of treatment success ratio.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 1,576 TB patients were recorded in TCIS in July September, 2020 and 1,145 TB cases were included in e-PSS in January March, 2021. The distribution of patient demographic and clinical features was similar between the two groups. A larger proportion from the e-PSS group visited the community doctor in the first three days compared with the TCIS group (48.91 versus 29. 76 % respectively). Medication adherence was also higher in the e-PSS group during the 6 months of treatment than in the TCIS group (84. 28 versus 80.3 3 % respectively). Treatment success was 92.52% in the e-PSS group and 92.07% in the TCIS group. Multivariate logistic regress ion analysis demonstrated that adjusted odds ratios for compliant first follow up visit, medication adherence and favorable treatment outcome in the e-PSS versus TCIS groups were 2.94 (95% 2.47 3.50), 1.33 (95% 1.08 1.63), and 1. 12 (95% CL: 0.79 1.57) respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This study revealed improvements in TB care following an intervention to monitor treatment digitally in patients in Wuhan, China.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1033532","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T07:01:30Z","timestamp":1677654090000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Digitizing tuberculosis treatment monitoring in Wuhan city, China, 2020\u20132021: Impact on medication adherence"],"prefix":"10.3389","volume":"11","author":[{"given":"Mengxian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Najmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aashifa","family":"Yaqoob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.ijid.2022.03.011","article-title":"The WHO global tuberculosis 2021 REport\u2013not so good news and turning the tide back to end TB","volume":"124","author":"Chakaya","year":"2022","journal-title":"Int J Infect Dis."},{"key":"B2","unstructured":"2022"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/s41591-018-0224-2","article-title":"A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis","volume":"24","author":"Imperial","year":"2018","journal-title":"Nat Med."},{"key":"B4","year":"2017","journal-title":"Guidelines for Treatment of Drug-Susceptible Tuberculosis and Patient Care"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.5588\/ijtld.12.0080","article-title":"Implementation and community involvement in DOTS strategy: a systematic review of studies in China","volume":"16","author":"Hou","year":"2012","journal-title":"Int J Tuberc Lung Dis."},{"key":"B6","first-page":"63","article-title":"Systematic review of directly observed therapy on tuberculosis control in China","volume":"27","author":"Wang","year":"2006"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1002595","DOI":"10.1371\/journal.pmed.1002595","article-title":"Adherence interventions and outcomes of tuberculosis treatment: a systematic review and meta-analysis of trials and observational studies","volume":"15","author":"Alipanah","year":"2018","journal-title":"PLoS Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0155147","DOI":"10.1371\/journal.pone.0155147","article-title":"Psychological and educational intervention to improve tuberculosis treatment adherence in Ethiopia based on health belief model: a cluster randomized control trial","volume":"11","author":"Tola","year":"2016","journal-title":"PLoS ONE."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1801363","DOI":"10.1183\/13993003.01363-2018","article-title":"Evaluating the potential costs and impact of digital health technologies for tuberculosis treatment support","volume":"52","author":"Nsengiyumva","year":"2018","journal-title":"Eur Respir J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1701596","DOI":"10.1183\/13993003.01596-2017","article-title":"The impact of digital health technologies on tuberculosis treatment: a systematic review","volume":"51","author":"Ngwatu","year":"2018","journal-title":"Eur Respir J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e100268","DOI":"10.1136\/bmjhci-2020-100268","article-title":"Effect of a phone reminder system on patient-centered tuberculosis treatment adherence among adults in Northwest Ethiopia: a randomised controlled trial","volume":"28","author":"Gashu","year":"2021","journal-title":"BMJ Health Care Inform"},{"key":"B12","doi-asserted-by":"publisher","first-page":"CD006594","DOI":"10.1002\/14651858.CD006594.pub3","article-title":"Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment","volume":"2014","author":"Liu","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"100098","DOI":"10.1016\/j.jctube.2019.100098","article-title":"Doshi RP. Synchronous and asynchronous video observed therapy (VOT) for tuberculosis treatment adherence monitoring and support","volume":"17","author":"Garfein","year":"2019","journal-title":"J Clin Tuberc Other Mycobact Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"00493","DOI":"10.1183\/13993003.00493-2020","article-title":"Video-observed therapy and medication adherence for tuberculosis patients: randomised controlled trial in Moldova","volume":"56","author":"Ravenscroft","year":"2020"},{"key":"B15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40249-021-00818-3","article-title":"Effect of using electronic medication monitors on tuberculosis treatment outcomes in China: a longitudinal ecological study","volume":"10","author":"Wang","year":"2021","journal-title":"Infect Dis Poverty."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1001876","DOI":"10.1371\/journal.pmed.1001876","article-title":"Effectiveness of electronic reminders to improve medication adherence in tuberculosis patients: a cluster-randomised trial","volume":"12","author":"Liu","year":"2015","journal-title":"PLoS Med"},{"key":"B17","first-page":"9","author":"Wuhan Municipal Statistics","year":"2020","journal-title":"Wuhan Statistical Yearbook 2020."},{"key":"B18","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/amiajnl-2013-002001","article-title":"Electronic recording and reporting system for tuberculosis in China: experience and opportunities","volume":"21","author":"Huang","year":"2014","journal-title":"J Am Med Inform Assoc"},{"key":"B19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.46234\/ccdcw2020.049","article-title":"Underreporting of notifiable pulmonary tuberculosis cases to the national tuberculosis information management system\u2014China","volume":"2","author":"Li","year":"2020"},{"key":"B20","first-page":"708","article-title":"CJA. Preliminary report of a mobile supervision application used for treatment management in patients with tuberculosis in Tongzhou District, Beijing in 2016","volume":"39","author":"Xie","year":"2017","journal-title":"Chin Jour Of Antituberculosis"},{"key":"B21","first-page":"23","article-title":"Strengthen the supervision and management for tuberculosis patients with mobile internet technology","volume":"5","author":"Jian","year":"2016"},{"key":"B22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/23744235.2019.1688862","article-title":"Ensuring tuberculosis treatment adherence with a mobile-based CARE-call system in Thailand: a pilot study","volume":"52","author":"Ratchakit-Nedsuwan","year":"2020","journal-title":"Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1568826","DOI":"10.1080\/16549716.2019.1568826","article-title":"Outcomes and implementation challenges of using daily treatment regimens with an innovative adherence support tool among HIV-infected tuberculosis patients in Karnataka, India: a mixed-methods study","volume":"12","author":"Thekkur","year":"2019","journal-title":"Glob Health Action."}],"updated-by":[{"DOI":"10.3389\/fpubh.2023.1191444","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000}}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1033532\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T11:53:15Z","timestamp":1680609195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1033532\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":23,"alternative-id":["10.3389\/fpubh.2023.1033532"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1033532","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fpubh.2023.1191444","asserted-by":"object"}]},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"article-number":"1033532"}}